Repositioning Salirasib as a new antimalarial agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repositioning Salirasib as a new antimalarial agent

Published:2019 Issue:9 Volume:10 Page:1599-1605
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Porta Exequiel O. J.¹²³⁴⁵^ORCID,Bofill Verdaguer Ignasi⁶⁷⁸⁹¹⁰,Perez Consuelo¹¹¹²¹³⁴⁵,Banchio Claudia¹¹¹²¹³⁴⁵^ORCID,Ferreira de Azevedo Mauro¹⁴¹⁵¹⁶¹⁰,Katzin Alejandro M.⁶⁷⁸⁹¹⁰^ORCID,Labadie Guillermo R.¹²³⁴⁵^ORCID

Affiliation:

1. Instituto de Química Rosario

2. UNR

3. CONICET

4. Rosario

5. Argentina

6. Departamento de Parasitología

7. Instituto de Ciências Biomédicas

8. Universidade de São Paulo

9. São Paulo

10. Brazil

11. Instituto de Biología Molecular y Celular (IBR-CONICET-UNR)

12. Facultad de Ciencias Bioquímicas y Farmacéuticas

13. Universidad Nacional de Rosario

14. Departamento de Biociências

15. Universidade Federal de São Paulo

16. Santos

Abstract

Repurposing strategies present an enormous advantage for drug discovery, especially in malaria, where resources are scarce.

Funder

Universidad Nacional de Rosario

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fondo para la Investigación Científica y Tecnológica

Consejo Nacional de Investigaciones Científicas y Técnicas

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00298G

Reference30 articles.

1. WHO, World malaria report 2017

2. New developments in anti-malarial target candidate and product profiles

3. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria

4. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies

5. Antimalarial drug discovery: efficacy models for compound screening

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipophilic modification of salirasib modulates the antiproliferative and antimigratory activity;Bioorganic & Medicinal Chemistry;2023-09

2. Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities;Frontiers in Pharmacology;2023-07-27

3. Bis-1,2,3-triazole derivative as an efficient corrosion inhibitor for mild steel in hydrochloric acid environment: Insights from experimental and computational analysis;Inorganic Chemistry Communications;2023-07

4. Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases;European Journal of Medicinal Chemistry;2023-06

5. A Quinquennial Review on Recent Advancements and Developments in Search of Anti-malarial Agents;Current Topics in Medicinal Chemistry;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3